Diagnostic Challenge. Department of Pathology,
|
|
- Lydia Newton
- 8 years ago
- Views:
Transcription
1 Cytology of Pleural Fluid as a Diagnostic Challenge Paavo Pääkkö,, MD, PhD Chief Physician and Head of the Department Department of Pathology, Oulu University Hospital,, Finland
2 Oulu University Hospital
3 General overview of cytology of pleural effusions! Exfoliative cytological examination of pleural effusions common method for determining whether effusion is benign or malignant! Effusions subdivided into transudates and exudates depending on the protein content! Transudates result from alterations in hydrostatic or oncotic pressure, often due to systemic factors, e.g. congestive heart failure! Exudates result from pathological processes localized to the serosal membranes => higher protein content and cellularity increased compared to transudates, e.g. infections
4 Utility and limitations of cytology of pleural effusions! Cells exfoliated into effusion fluid can be examined as cytology smears, liquid-based preparations, cytospin preparations, or cell blocks! Most of the exudates benign! The absence of malignant cells does not rule out malignancy! Only % of malignant mesotheliomas,, and % of cancers metastatic to the pleura diagnosed by exfoliative cytology
5 Cytology vs. histology! Exfoliative cytology has of limited usefulness in diagnosing malignant mesothelioma! Benign reactive mesothelial cells may have features that mimic malignancy,, and malignant mesotheliomas may be cytologically bland! Without evidence of invasion of underlying tissues, diagnosis of mesothelioma on cytologic grounds maybe difficult! Sarcomatous mesotheliomas typically do not shed cells into effusion
6 Cytological features of malignancy! Cancer cells as individual cells, sheets of cohesive cells, and three-dimensional spherical clusters, called morulae! Papillary or acinar structures! Usually the number of malignant cells high, rarely a few! Presence of psammoma bodies! Enlarged cells with enlarged nuclei, coarse chromatin, prominent nucleoli! Mitoses, atypical mitoses,, and necrotic debris
7 Reactive atypia of mesothelial cells! Benign mesothelial cells exfoliate easily and display a spectrum of reactive changes from minimal reactive change to highly atypical reactive change, mimicking malignancy! Reactive mesothelial cells shed as invidual cells, in clusters or sheets, with adjacent cells separated from one another by spaces referred to as windows
8 Cytological features of reactive mesothelial cells! Nuclei round or oval with distict nuclear membranes, chromatin vesicular or finely granular,, and cytoplasm adundant and darkly-stained! Peripheral cytoplasm stains darker than central cytoplasm,, and microvilli around the periphery result in fuzzy rim or border! Binucleation or multinucleation frequent! Cytoplasmic vacuoles may compress the nucleus, suggesting the signet ring cells of adenocarcinoma
9 Reactive mesothelial cells
10 Cytological features of malignant mesothelioma! Malignant mesotheliomas cause <1 % of malignant pleural effusions,, and only epithelial malignant mesotheliomas likely exfoliate cells into effusion fluids! Malignant mesothelioma cells lack the significant degree of cytological pleomorphism! Cells arranged in sheets, clusters, morulae or papillary structures
11 Hints for correct interpretation! Atypical reactive mesothelial cells blend with cells with lesser degrees of reactive atypia within a benign effusion, giving the impression of one population of cells! In cases of malignancy, reactive mesothelial cells and malignant cells often appear as two separate and distinct population of cells! It is necessary to first determine if cells in a fluid are truly malignant before secondarily determining the type of malignancy! Immunohistochemical confirmation that atypical cells are mesothelial in origin does not help to distinguish between reactive mesothelial cell proliferation and mesothelioma
12 Case 1! 60-year old man! Exposed to asbestos! Hydrothorax and pleural plaques! Cytological specimen taken from pleural cavity
13
14
15 Calretinin CK 5/6 CK7 EMA
16 Conclusion from Case 1! Strong suspicion for malignancy, fitting rather for malignant mesothelioma than metastatic adenocarcinoma! The diagnosis of malignant mesothelioma was later confirmed by histological sample
17 Calretinin WT1 EMA
18 Case 2! 76-year old male! Suspicion for lung malignancy! Hydrothorax! An aspiration from left pleural cavity performed, and cytological analyses requested
19
20 TTF-1 CK 7 CK 5/6
21 EMA E-Cadherin Calretinin
22 Conclusion from Case 2! Strong suspicion for a metastatic carcinoma! TTF-1 positivity suggests for pulmonary origin of the carcinoma
23 Case 3! 76-year old female! Breast carcinoma operated 6 years ago! Fluid in the pleural cavity and both lungs contain tumour infiltrations! Pleural cytology requested
24
25 PAN-CK CK 5/6 Estrogen receptor
26 Connclusion from Case 3! Strong suspicion for a metastatic carcinoma! Estrogen receptor-positivity suggests for a metastatic breast carcinoma
27 Case 4! 76-year old male! Laryngeal squamous cell carcinoma operated 1993! COPD! Heavy smoker! Abundant fluid in the left pleural cavity
28
29
30 CK 7 CK 7 TTF-1 Calretinin CK 5/6
31 Conclusion from Case 4! Mild suspicion for a malignancy, origin of which possibly in the lungs! In addition,, the cell population contained atypical mesothelial cell proliferation
32 Summary and conclusions! Most of the exudates benign! The absence of malignant cells does not rule out malignancy! Malignant mesotheliomas cause <1 % of malignant pleural effusions,, and only epithelial malignant mesotheliomas likely exfoliate cells into effusion fluids! It is necessary to first determine if cells in a fluid are truly malignant before secondarily determining the type of malignancy! Immunohistochemistry of histological sections from a cell block may help to determine the type of malignancy
33
Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium
Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium Introduction 3 cavities with the same embryologic origin the mesoderme Pleura Exudates Pleura Peritoneum Pericardium 22%
More informationImmunohistochemistry on cytology specimens from pleural and peritoneal fluid
Immunohistochemistry on cytology specimens from pleural and peritoneal fluid Dr Naveena Singh Consultant Pathologist Bart health NHS Trust London United Kingdom Disclosures and Acknowledgements I have
More informationHow To Diagnose And Treat A Tumour In An Effusion
Effusions of the Serous Cavities Annika Dejmek Professor/Consultant in Cytopathology Clinical Pathology; Department of Laboratory Medicine, Malmö, Lund University 5th EFCS Tutorial Trondheim 2012 Pleura
More informationCytopathology Case Presentation #8
Cytopathology Case Presentation #8 Emily E. Volk, MD William Beaumont Hospital, Troy, MI Jonathan H. Hughes, MD Laboratory Medicine Consultants, Las Vegas, Nevada Clinical History 44 year old woman presents
More informationEffusions: Mesothelioma and Metastatic Cancers
Effusions: Mesothelioma and Metastatic Cancers Malignant Mesothelioma Incidence: 2,500 cases/year ~60-80% pts with pleural MM relationship with asbestos exposure Other risk factors: radiation, other carcinogens,
More informationMALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY
MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo, Finland 2nd Nordic Conference on Applied
More informationMALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY
MALIGNANT MESOTHELIOMA CLASSIFICATION MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo,
More informationPATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet
PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry M. Praet Pathology of the Pleura Normal serosa: visceral and parietal layers Inflammation Neoplasia: Primary: mesothelioma
More informationOutline. Workup for metastatic breast cancer. Metastatic breast cancer
Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30
More informationPractical Effusion Cytology
Practical Effusion Cytology A Community Pathologist s Approach to Immunocytochemistry in Body Fluid Cytology Emily E. Volk, MD William Beaumont Hospital Troy, MI College of American Pathologists 2004.
More informationThe develpemental origin of mesothelium
Mesothelioma Tallinn 14.12.06 Henrik Wolff Finnish Institute of Occupational Health The develpemental origin of mesothelium Mesodermal cavities (pleura, peritoneum and pericardium ) are lined with mesenchymal
More informationCase of the. Month October, 2012
Case of the Month October, 2012 Case The patient is a 47-year-old male with a 3-week history of abdominal pain. A CT scan of the abdomen revealed a suggestion of wall thickening at the tip of the appendix
More informationVideo Microscopy Tutorial 5
Video Microscopy Tutorial 5 Lool Alikes in Effusion Cytology:Review of Diagnostic Challenges Claire Michael, MD There are no disclosures necessary. Look-Alikes in Effusion Cytology: Review of Diagnostic
More informationUpdate on Mesothelioma
November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical
More informationCytology of Effusion Fluids. Cytology of Effusion Fluids. Types of Effusion Fluids. Anatomy. Causes of Effusions. Sampling of Effusion Fluids
Cytology of Effusion Fluids John W. Wong, MD, FRCPC Sunnybrook Health Sciences Centre Assistant Professor, Laboratory Medicine and Pathobiology Faculty of Medicine, University of Toronto November 10, 2012
More informationCarcinosarcoma of the Ovary
Carcinosarcoma of the Ovary A Rare Finding Presented By: Kathryn Kiely Anisa I. Kanbour School of Cytotechnology of the University of Pittsburgh Medical Center Pittsburgh, PA Patient History 55 year old
More informationMalignant Mesothelioma in Body Fluids - with Special Reference to Differential Diagnosis from Metastatic Adenocarcinoma -
The Korean Journal of Pathology 2009; 43: 458-66 DOI: 10.4132/KoreanJPathol.2009.43.5.458 Malignant Mesothelioma in Body Fluids - with Special Reference to Differential Diagnosis from Metastatic Adenocarcinoma
More informationPleural and Pericardial fluids a one year analysis
Pleural and Pericardial fluids a one year analysis Dr Olafsdottir Dr J Williams Department of Cytology, Llandough Hospital Contents Background Standards Aims/Questions Investigation group Results Conclusions
More informationORIGINAL ARTICLES. Materials and Methods
ORIGINAL ARTICLES Cytomorphologic Features of Metastatic Urothelial Carcinoma in Serous Effusions Cheng Cheng Huang, M.D., PH.D., 1 Anoja Attele, M.D., 1 and Claire W. Michael, M.D. 2 * Metastatic urothelial
More informationALTHOUGH excellent accounts have been published in recent years of
THE EXFOLIATIVE CYTOLOGY OF DIFFUSE MALIGNANT MESOTHELIOMA BERNARD NAYLOR Department of Pathology, University of Michigan, Ann Arbor, Michigan, U.S.A. PLATE~ LXXXVI-XCI ALTHOUGH excellent accounts have
More informationDiagnosis of Mesothelioma Pitfalls and Practical Information
Diagnosis of Mesothelioma Pitfalls and Practical Information Mary Beth Beasley, M.D. Mt Sinai Medical Ctr Dept of Pathology One Gustave L Levy Place New York, NY 10029 (212) 241-5307 mbbeasleymd@yahoo.com
More informationPRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT
PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT Dott. Francesco Pontieri (*) U.O. di Anatomia Patologica P.O. di Rossano (CS) Dott. Gian Franco Zannoni Anatomia Patologica Facoltà di Medicina e Chirurgia
More informationNotice of Faculty Disclosure
The Diagnosis of Malignant Mesothelioma Andrew Churg, MD Department of Pathology University of British Columbia Vancouver, BC, Canada achurg@mail.ubc.ca Notice of Faculty Disclosure In accordance with
More informationAcadémie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger. Immunohistochemistry in malignant mesotheliomas
Académie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger Immunohistochemistry in malignant mesotheliomas Françoise Thivolet-Béjui Groupement Hospitalier Est Lyon-Bron
More informationEffusion cytology. Dr Alpha Tsui Royal Melbourne Hospital 2008
Effusion cytology Dr Alpha Tsui Royal Melbourne Hospital 2008 General points: -large unilateral effusion (>1 litre) in the elderly is highly suspicious for malignancy -effusions associated with malignancies
More informationThe Diagnosis of Cancer in the Pathology Laboratory
The Diagnosis of Cancer in the Pathology Laboratory Dr Edward Sheffield Christmas Select 74 Meeting, Queen s Hotel Cheltenham, 3 rd December 2014 Agenda Overview of the pathology of cancer How specimens
More informationDisclosures. Learning Objectives. Effusion = Confusion. Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell!
Disclosures Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell! No Relevant Financial Relationships with Commercial Interests Syed Z. Ali, M.D. Syed Z. Ali, M.D. Associate Professor of
More informationMale. Female. Death rates from lung cancer in USA
Male Female Death rates from lung cancer in USA Smoking represents an interesting combination of an entrenched industry and a clearly drug-induced cancer Tobacco Use in the US, 1900-2000 5000 100 Per Capita
More informationHow To Test For Cancer
Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell! Effusion = Confusion Syed Z. Ali, M.D. Professor of Pathology and Radiology The Johns Hopkins Hospital Baltimore, Maryland Diagnostic
More informationHKCPath Anatomical Pathology Peer Review and Scores : PDF version for download
AP2003R1 http://hkcpath.org. Correspondence: pkhui@ha.org.hk 1of 10 07/08/2003 HKCPath Anatomical Pathology Peer Review and Scores : PDF version for download AP141 Bone Marrow: Metastatic Carcinoma from
More informationSeattle. Case Presentations. Case 1. 76 year old female with a history of breast cancer 12 years ago. Now presents with a pleural effusion.
Seattle Montreal IAP September 2006 Case Presentations Allen M. Gown, M.D. Medical Director and Chief Pathologist PhenoPath Laboratories Clinical Professor of Pathology University of British Columbia Case
More informationASBESTOS EXPOSURE AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA Gorantla Sambasivarao 1, Namballa Usharani 2, Tupakula Suresh Babu 3
ASBESTOS EXPOSURE AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA Gorantla Sambasivarao 1, Namballa Usharani 2, Tupakula Suresh Babu 3 HOW TO CITE THIS ARTICLE: Gorantla Sambasivarao, Namballa Usharani,
More informationA 70-year old Man with Pleural Effusion
Mesothelioma Diagnosis: Pitfalls and Latest Updates S Klebe and DW Henderson Recommendations Indisputable malignant cells on cytomorphological criteria which demonstrate a mesothelial phenotype, which
More information20 Diagnostic Cytopathology, Vol 36, No 1 ' 2007 WILEY-LISS, INC.
Utility of WT-1, p63, MOC31, Mesothelin, and Cytokeratin (K903 and CK5/6) Immunostains in Differentiating Adenocarcinoma, Squamous Cell Carcinoma, and Malignant Mesothelioma in Effusions Robert T. Pu,
More informationFine Needle Aspiration Cytologic Features of Well-Differentiated Papillary Mesothelioma in the Pleura
The Korean Journal of Pathology 2009; 43: 583-8 DOI: 10.4132/KoreanJPathol.2009.43.6.583 Fine Needle Aspiration Cytologic Features of Well-Differentiated Papillary Mesothelioma in the Pleura - A Case Report
More informationDESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE
DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE Ryan Granger University of Rhode Island Cytotechnology program May 2, 2015 ASCT Annual Meeting Nashville, Tennessee DESMOPLASTIC SMALL ROUND
More informationThe Use of Immunohistochemistry to Distinguish Reactive Mesothelial Cells From Malignant Mesothelioma in Cytologic Effusions
The Use of Immunohistochemistry to Distinguish Reactive Mesothelial Cells From Malignant Mesothelioma in Cytologic Effusions Farnaz Hasteh, MD 1 ; Grace Y. Lin, MD, PhD 1 ; Noel Weidner, MD 1 ; and Claire
More informationThinPrep Non-Gyn Lecture Series. Body Fluid Cytology
ThinPrep Non-Gyn Lecture Series Body Fluid Cytology Benefits of ThinPrep Technology The use of ThinPrep Non-Gyn for body fluid specimens: Optimizes cell preservation Standardizes specimen preparation Simplifies
More informationThe diagnostic usefulness of tumour markers CEA and CA-125 in pleural effusion
Malaysian J Path01 2002; 24(1) : 53-58 The diagnostic usefulness of tumour markers CEA and CA-125 in pleural effusion Pavai STHANESHWAR MD, Sook-Fan YAP FRCPath, FRCPA and Gita JAYARAM MDPath, MRCPath
More informationA. Pericardial smear. Examination of the pericardial aspirate can provide useful diagnostic information.
5. PERICARDIUM Heart is encased by the pericardium which has a visceral layer (a) covering the heart and the parietal layer (b). In normal states it is thin, transparent and the myocardium can be seen
More informationINFLAMMATORY PLEURAL EFFUSION
PLEURA- LESIONS LESIONS OF PLEURA Primary Intra pleural bacterial infections Neoplasm (mesothelioma) Secondary A complication of some underlying disease PLEURAL EFFUSION Common manifestation of both primary
More informationYOUR LUNG CANCER PATHOLOGY REPORT
UNDERSTANDING YOUR LUNG CANCER PATHOLOGY REPORT 1-800-298-2436 LungCancerAlliance.org A GUIDE FOR THE PATIENT 1 CONTENTS What is a Pathology Report?...3 The Basics...4 Sections of a Pathology Report...7
More informationCytology of Malignant Mesothelioma
31 Cytology of Malignant Mesothelioma Richard M. DeMay Because patients with mesotheliomas frequently present with effusions, cytologic examination of the effusion fluid may be the first diagnostic study.
More informationSilent Time-Bomb, Mesothelioma
Silent Time-Bomb, Mesothelioma ーClinical Pathology Shotaro Maeda Tama-Nagayama Hospita,lNippon Medical School JAPAN Mesothelioma 1 General remarks 2 Pathology 3 Cytology 4 6 cases of the mesothelioma diagnosed
More informationNeoplasms of the LUNG and PLEURA
Neoplasms of the LUNG and PLEURA 2015-2016 FCDS Educational Webcast Series Steven Peace, BS, CTR September 19, 2015 2015 Focus o Anatomy o SSS 2000 o MPH Rules o AJCC TNM 1 Case 1 Case Vignette HISTORY:
More informationCase presentation. Awatif Al-Nafussi
Case presentation Awatif Al-Nafussi Case History 49 year old DVT & small PE June 08, Pelvic mass Ca125 33 Laparotomy-TAHBSO, drainage of ascites Ovarian carcinoma Clinical diagnosis Multiple specimens
More informationSurgeons Role in Symptom Management. A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND
Surgeons Role in Symptom Management A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND Conditions PLEURAL Pleural effusion Pneumothorax ENDOBRONCHIAL Haemoptysis
More informationThe Diagnostic Value of Pleural Fluid Cytology in Benign and Malignant Pleural Effusions
Med. J. Cairo Univ., Vol. 80, No. 2, June: 95-103, 2012 www.medicaljournalofcairouniversity.com The Diagnostic Value of Pleural Fluid Cytology in Benign and Malignant Pleural Effusions SAMAR A. EL-SHEIKH,
More informationInformation Model Requirements of Post-Coordinated SNOMED CT Expressions for Structured Pathology Reports
Information Model Requirements of Post-Coordinated SNOMED CT Expressions for Structured Pathology Reports W. Scott Campbell, Ph.D., MBA James R. Campbell, MD Acknowledgements Steven H. Hinrichs, MD Chairman
More informationCase Report Predominantly Fibrous Malignant Mesothelioma in a Cat
SAGE-Hindawi Access to Research Volume 2010, Article ID 396794, 4 pages doi:10.4061/2010/396794 Case Report Predominantly Fibrous Malignant Mesothelioma in a Cat Alexander Th. A. Weiss, Afonso B. da Costa,
More informationTUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD
TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD Victor E. Reuter, MD Memorial Sloan-Kettering Cancer Center reuterv@mskcc.org 66 th Annual Pathology Seminar California Society of Pathologists Short
More informationDiseases. Inflammations Non-inflammatory pleural effusions Pneumothorax Tumours
Pleura Visceral pleura covers lungs and extends into fissures Parietal pleura limits mediastinum and covers dome of diaphragm and inner aspect of chest wall. Two layers between them (pleural cavity) contains
More informationCase based applications part III
Case based applications part III Los Angeles Society Of Pathologists January 25, 2014 Sanja Dacic, MD, PhD University of Pittsburgh Medical Center 1 CASE 1 A 44-year-old woman with multiple lung nodules.
More informationOvarian tumors Ancillary methods
Ovarian tumors Ancillary methods Ovarian tumor course Oslo, 24-25/11/14 Prof. Ben Davidson, MD PhD Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway Division of
More informationESSENTIALS OF FLUID CYTOLOGY
ESSENTIALS OF FLUID CYTOLOGY Gia-Khanh Nguyen 2009 ESSENTIALS OF FLUID CYTOLOGY Gia-Khanh Nguyen, M.D. Professor Emeritus Department of Laboratory Medicine and Pathology Faculty of Medicine and Dentistry
More informationChanges in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred
More information3-F. Pathology of Mesothelioma
3-F. Pathology of Mesothelioma Kouki Inai Professor of Department of Pathology, Graduate School of Biomedical Science, Hiroshima University Introduction Mesothelioma is a peculiar type of malignancy, which
More informationPathology of lung cancer
Pathology of lung cancer EASO COURSE ON LUNG CANCER AND MESOTHELIOMA DAMASCUS (SYRIA), MAY 3-4, 2007 Gérard ABADJIAN MD Pathologist Associate Professor, Saint Joseph University Pathology Dept. Hôtel-Dieu
More informationImmunohistochemical differentiation of metastatic tumours
Immunohistochemical differentiation of metastatic tumours Dr Abi Wheal ST1. TERA 3/2/14 Key points from a review article written by Daisuke Nonaka Intro Metastatic disease is the initial presentation in
More informationNo Difference Between Mesothelioma and Pulmonary and Nonpulmonary Adenocarcinoma DO NOT DUPLICATE. Malignancy is a common cause of effusions of the
NONGYNECOLOGIC CYTOPTHOLOGY CK5/6 in Effusions No Difference etween Mesothelioma and Pulmonary and Nonpulmonary denocarcinoma nnika Dejmek, M.D., Ph.D. Objective To test the performance of CK5/6 for the
More informationATLAS OF HEAD AND NECK PATHOLOGY THYROID PAPILLARY CARCINOMA
Papillary carcinoma is the most common of thyroid malignancies and occurs in all age groups but particularly in women under 45 years of age. There is a high rate of cervical metastatic disease and yet
More informationCase Report A Cause of Bilateral Chylothorax: A Case of Mesothelioma without Pleural Involvement during Initial Diagnosis
Case Reports in Pulmonology Volume 2015, Article ID 962504, 4 pages http://dx.doi.org/10.1155/2015/962504 Case Report A Cause of Bilateral Chylothorax: A Case of Mesothelioma without Pleural Involvement
More informationToday s Topics. Tumors of the Peritoneum in Women
Today s Topics Tumors of the Peritoneum in Women Charles Zaloudek, M.D. Department of Pathology 505 Parnassus Ave., M563 University of California, San Francisco San Francisco, CA USA charles.zaloudek@ucsf.edu
More informationMAJOR PARADIGM SHIFT IN EARLY 1990S IN UNDERSTANDING RENAL CANCER
Renal tumours WHO 4 MAJOR PARADIGM SHIFT IN EARLY 1990S IN UNDERSTANDING RENAL CANCER Molecular differential pathology of renal cell tumours G. KOVACS A CLASSIFICATION BASED ON UNDERSTANDING THE GENETIC
More informationThe Value of Thyroid Transcription Factor-1 in Cytologic Preparations as a Marker for Metastatic Adenocarcinoma of Lung Origin
Anatomic Pathology / TTF-1 IN CYTOLOGY OF BODY FLUIDS The Value of Thyroid Transcription Factor-1 in Cytologic Preparations as a Marker for Metastatic Adenocarcinoma of Lung Origin Jonathan L. Hecht, MD,
More informationPrimary -Benign - Malignant Secondary
TUMOURS OF THE LUNG Primary -Benign - Malignant Secondary The incidence of lung cancer has been increasing almost logarithmically and is now reaching epidemic levels. The overall cure rate is very low
More informationUses and Abuses of Pathology in Asbestos-exposed Populations
Uses and Abuses of Pathology in Asbestos-exposed Populations Jerrold L. Abraham, MD Department of Pathology State University of New York Upstate Medical University Syracuse, NY, 13210 USA The term: Asbestosis,
More informationHow To Defend The Mesothelioma Case
Defending the Mesothelioma Case: Types, Alternative Causes, and Working Up the Case Mary Price Birk Baker & Hostetler, LLP 303 East 17 th Avenue, Suite 1100 Denver, CO 80202 (303) 764-4041 (303) 861-7805
More informationHistopathology of Major Salivary Gland Neoplasms
Histopathology of Major Salivary Gland Neoplasms Sam J. Cunningham, MD, PhD Faculty Advisor: Shawn D. Newlands, MD, PhD Faculty Advisor: David C. Teller, MD The University of Texas Medical Branch, Department
More informationA Cytokeratin- and Calretinin-negative Staining Sarcomatoid Malignant Mesothelioma
A Cytokeratin- and Calretinin-negative Staining Sarcomatoid Malignant Mesothelioma MICHAEL G. HURTUK and MICHELE CARBONE Cardinal Bernadin Cancer Center, Cancer Immunology Program, Department of Pathology,
More informationCase Report Malignant Mesothelioma Mimicking Invasive Mammary Carcinoma in a Male Breast
Case Reports in Oncological Medicine Volume 2015, Article ID 298523, 4 pages http://dx.doi.org/10.1155/2015/298523 Case Report Malignant Mesothelioma Mimicking Invasive Mammary Carcinoma in a Male Breast
More informationINFLAMMATION AND REACTIVE CHANGES IN CERVICAL EPITHELIUM
INFLAMMATION AND REACTIVE CHANGES IN CERVICAL EPITHELIUM Inflammation is a response of a tissue to injury, often caused by invading microorganisms. The suffix which indicates inflammation is "-itis" (the
More informationRare Thoracic Tumours
Rare Thoracic Tumours 1. Epithelial Tumour of Trachea 1 1.1 General Results Table 1. Epithelial Tumours of Trachea: Incidence, Trends, Survival Flemish Region 2001-2010 Both Sexes Incidence Trend EAPC
More informationMalignant Mesothelioma Diagnosed by Bronchoscopic Biopsy
CASE REPORT http://dx.doi.org/10.4046/trd.2015.78.3.297 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2015;78:297-301 Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy Yeon-Hee Park,
More informationAccuracy of pleural effusion cytopathology. Fatemeh Samiee Rad
Accuracy of pleural effusion cytopathology Fatemeh Samiee Rad Assistant professor of Pathology, Qazvin Metabolic Disease Research Center, Faculty of Medicine, Qazvin University of Medical Sciences, Qazvin,
More informationMALIGNANT MESOTHELIOMA: A TYPICAL PRESENTATION IN AN ATYPICAL PATIENT
MALIGNANT MESOTHELIOMA: A TYPICAL PRESENTATION IN AN ATYPICAL PATIENT Written by: Karyn Varley MS, SCT(ASCP) The donating laboratory would like to remain anonymous. PATIENT HISTORY 28 year old female Lived
More informationBasic Professional Training Program for Associate Medical Technologist
Basic Professional Training Program for Associate Medical Technologist Basic Cytology Part 2 (Preparartion and normal morphology) Normal Morphology in Liquid based Gynecologic Cytology Speaker: Mr. Fung
More informationCase presentation: Mesothelioma of the tunica vaginalis. Dr Ben Shepherd Pathology Queensland Princess Alexandra Hospital Brisbane
Case presentation: Mesothelioma of the tunica vaginalis Dr Ben Shepherd Pathology Queensland Princess Alexandra Hospital Brisbane A 76 year old man presented June 2011 with a 6 month history of painless
More informationFNA Cytology of Mediastinal Lesions. Presenters: Xiaoqi Lin, M.D., Ph.D. Ritu Nayar, M.D.
Disclosure information The speakers have no relationship that represents a possible conflict of interest with respect to the content of this presentation. FNA Cytology of Mediastinal Lesions Presenters:
More informationCytology of Lymph Nodes
Indications Cytology of Lymph Nodes Lymph node enlargement That was easy Mary Anna Thrall Don Meuten Indications Lymph node enlargement Suspect metastasis Normal sized lymph nodes are Normal Do NOT aspirate
More informationBreast Fine Needle Aspiration Cytology Reporting : A Study of Application of Probabilistic Approach
54 Original Study Indian Medical Gazette FEBRUARY 2013 Breast Fine Needle Aspiration Cytology Reporting : A Study of Application of Probabilistic Approach Amrish N. Pandya, Professor & Head, IHBT Department,
More informationMalignant Mesothelioma Electron Microscopy
33 Malignant Mesothelioma Electron Microscopy Raoul Fresco In spite of recent advances in immunocytochemistry, electron microscopy continues to be the gold standard for the differential diagnosis of mesothelioma
More informationIntroduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.
Disorders of Growth Introduction: Tumor Swelling / new growth / mass Two types of growth disorders: Non-Neoplastic Secondary / adaptation due to other cause. Neoplastic. Primary growth abnormality. Non-Neoplastic
More informationPleural Mesothelioma: An Institutional Experience of 66 Cases
The Korean Journal of Pathology 2014; 48: 91-99 ORIGINAL ARTICLE Pleural Mesothelioma: An Institutional Experience of 66 Cases Soomin Ahn In Ho Choi Joungho Han Jhingook Kim 1 Myung-Ju Ahn 2 Departments
More informationWORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14
WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14 BEFORE: M. Crystal: Vice-Chair HEARING: August 20, 2014 at Toronto Written DATE OF DECISION: December 4, 2014 NEUTRAL CITATION: 2014
More informationDistinguishing benign from malignant mesothelial
ORIGINAL ARTICLE IMP3 and GLUT-1 Immunohistochemistry for Distinguishing Benign From Malignant Mesothelial Proliferations Anna F. Lee, MDCM, PhD,*w Allen M. Gown, MD,wz and Andrew Churg, MD*w Abstract:
More informationClinical cases in Malignant Pleural Mesothelioma: Adherence to the ESMO Clinical Practice Guidelines
Clinical cases in Malignant Pleural Mesothelioma: Adherence to the ESMO Clinical Practice Guidelines Wieneke Buikhuisen The Netherlands Cancer Institute Amsterdam The Netherlands Case (1) Male, 56 year
More informationPROTOCOL OF THE RITA DATA QUALITY STUDY
PROTOCOL OF THE RITA DATA QUALITY STUDY INTRODUCTION The RITA project is aimed at estimating the burden of rare malignant tumours in Italy using the population based cancer registries (CRs) data. One of
More informationCytopathology of Pleural Mesotheliomas
Cytopathology of Pleural Mesotheliomas Gia-Khanh Nguyen, MD Key Words: Pleural mesothelioma; Epithelial mesothelioma; Sarcomatous mesothelioma; Mixed mesothelioma; Exfoliative cytology; Fineneedle aspiration
More informationWORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 171/08
WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 171/08 BEFORE: M.F. Keil : Vice-Chair M. Christie: Member Representative of Employers M. Ferrari: Member Representative of Workers HEARING:
More informationHistologic Classification and Differential Diagnosis of Mesothelioma
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 54 (1981), 173-180 Histologic Classification and Differential Diagnosis of Mesothelioma DARRYL CARTER, M.D. Department of Pathology, Yale University School of Medicine,
More informationNilesh P. Patel, MD, 1 Cullen A. Taylor, MD, 1* Edward A. Levine, MD, 2 Jacqueline K. Trupiano, MD, 1* and Kim R. Geisinger, MD 1.
Anatomic Pathology / PRIMARY PERITONEAL MESOTHELIOMA Cytomorphologic Features of Primary Peritoneal Mesothelioma in Effusion, Washing, and Fine-Needle Aspiration Biopsy Specimens Examination of 49 Cases
More informationJ of Evidence Based Med & Hlthcare, pissn- 2349-2562, eissn- 2349-2570/ Vol. 2/Issue 33/Aug. 17, 2015 Page 5063
PERITONEAL MALIGNANT MESOTHELIOMA: A RARE S. R. Dhamotharan 1, S. Shanthi Nirmala 2, F. Celine Foustina Mary 3, M. Arul Raj Kumar 4, R. Vinothprabhu 5 HOW TO CITE THIS ARTICLE: S. R. Dhamotharan, S. Shanthi
More informationMore than 2,500 people are diagnosed with mesothelioma in the UK each year.
This information is an extract from the booklet Understanding mesothelioma. You may find the full booklet helpful. We can send you a free copy see page 5. Contents Introduction Pleural mesothelioma Peritoneal
More informationSurvey of Mesothelioma Associated with Asbestos Exposure in Japan
The research and development and the dissemination projects related to the 13 fields of occupational injuries and illnesses Survey of Mesothelioma Associated with Asbestos Exposure in Japan Clinical characteristics
More informationGladwyn Leiman, MCCCh, FIAC, FRCPath Scott Anderson, MD
Cytology Works shop #5 Gladwyn Leiman, MCCCh, FIAC, FRCPath Scott Anderson, MD Disclosur re information The speakers have no relationship that represents a possible conflict of interest with respect to
More informationMultiple Primary and Histology Site Specific Coding Rules KIDNEY. FLORIDA CANCER DATA SYSTEM MPH Kidney Site Specific Coding Rules
Multiple Primary and Histology Site Specific Coding Rules KIDNEY 1 Prerequisites 2 Completion of Multiple Primary and Histology General Coding Rules 3 There are many ways to view the Multiple l Primary/Histology
More informationDeciduoid Mesothelioma:
Deciduoid Mesothelioma: Cytologic Presentation and Diagnostic Pitfalls Cheng Cheng Huang, M.D. and Claire W. Michael, M.D.* We report two cases of malignant deciduoid mesothelioma (MDM), a very rare variant
More informationHEALTH CARE FOR EXPOSURE TO ASBESTOS. 2010 The SafetyNet Centre for Occupational Health and Safety Research Memorial University www.safetynet.mun.
HEALTH CARE FOR PATIENTS WITH EXPOSURE TO ASBESTOS 2010 The SafetyNet Centre for Occupational Health and Safety Research Memorial University www.safetynet.mun.ca HEALTH CARE FOR PATIENTS WITH EXPOSURE
More informationProtocol applies to all primary borderline and malignant epithelial tumors, and malignant mesothelial neoplasms of the peritoneum.
Peritoneum Protocol applies to all primary borderline and malignant epithelial tumors, and malignant mesothelial neoplasms of the peritoneum. Protocol revision date: January 2004 No AJCC/UICC staging system
More information